Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $TRST.TO) (NYSE: $CTST) (CSE: $OILS.C) (OTCQB: $OILFF) (CSE: $BEV.C) (TSX: $FAF.TO)
Delta, Kelowna, BC –September 23 , 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Today's podcast overview/transcript
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts
In today’s podcast we look at a few early announcements.
But first, looking back at the big news from last week which was from CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST) who received a Notice of Licence Suspension under section 64(1) of the Cannabis Act. The Notice cites the Company's previous non-compliance with certain requirements of the Cannabis Act and the regulations made thereunder in respect of the matters that the Company has been discussing with Health Canada. The company then received notice from the Alberta Gaming, Liquor and Cannabis Commission, the Crown corporation in charge of wholesale distribution of cannabis products to licensed cannabis retailers in Alberta, advising the Company that the AGLC has determined that the Company's products sold to the AGLC will be returned to the Company pursuant to the terms of the Cannabis Supply Agreement between the Company and the AGLC. Under the terms of the Supply Agreement, goods sold to the AGLC may be returned to the Company for any reason and the Company will be responsible for the cost of the goods and all expenses related to the return.
The products to be returned constitute all or substantially all of the Company's products currently held at the AGLC and are valued at approximately $1.3 million in the aggregate. The AGLC operates independently of Health Canada. Health Canada has not ordered a recall in respect of any of the Company's products.
CannTrust remains fully focused on achieving complete regulatory compliance. The Company is committed to rebuilding the trust of all stakeholders, and looks forward to delivering high quality, innovative products to both its patients and customers in the future.
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) announced today it has entered into an agreement to acquire intellectual property pertaining to water-soluble cannabinoid formulations. Based around a Nano and Micro Emulsification process, the technology utilizes food grade emulsifiers already approved by Health Canada. These water-soluble cannabinoids are shelf stable, resulting in no constituent separation, and boast a rapid onset time.
"This nanotechnology increases onset time from over 90 minutes to less than 10 minutes when consuming cannabinoids in a beverage. We believe this represents a quantum leap for the industry, as fast onset is a pre-requisite for mass market acceptance of THC and CBD infused drinks." said Paul Pedersen, CEO of OILS.
Under the agreement, OILS will acquire the processing methodology and ingredient formulation from a private company led by a team with extensive experience in emulsifying hydrophobic molecules into various matrixes. The developers combine expert chemical engineering with tenured experience from one of the largest Canadian dairy product manufacturers. "This is a cannabis specific innovation built on proven and validated food and beverage technology," said Ryan Ko, Chief Technology Officer of Nextleaf Solutions. "The technology and formulation allow for versatile application into hot or cold liquids, semi-solid, or solid mediums. Homogeneity is crucial for a reliable consumer experience so that every bite or sip delivers a consistent amount of cannabinoids."
The Company's proprietary extraction, purification and refinement system paired with the newly acquired water-soluble formulation gives a superior advantage to Nextleaf's commercialization partners as products will represent cleaner ingredient profiles, minimizing the use of additives for flavor masking. OILS has granted an exclusive license to BevCanna Enterprises Inc. (CSE: BEV), a BC-based emerging leader in cannabis-infused beverages, for the use of intellectual property related to water-soluble cannabinoids for the development, manufacturing and sale of BevCanna products. Nextleaf also has a supply agreement with BevCanna to provide cannabinoids for the production of their products.
As consumer packaged goods companies enter the cannabis infused product landscape, OILS believes the scalability of its patented technology and ability to standardize ingredients is what sets it apart. Paul Pedersen, CEO of Nextleaf Solutions, "as the industry evolves, there's going to be increased demand for more sophisticated processing solutions to formulate standardized products."
Fire & Flower Holdings Corp. and its wholly-owned subsidiary Fire & Flower Inc. (TSX: FAF), today announced that its Chief Executive Officer, Trevor Fencott has been elected to the Board of Directors of the Canadian Chamber of Commerce.
As the "Voice of Canadian Business", the Canadian Chamber of Commerce is Canada's largest and most recognized business association in the country, which speaks with one unified voice on behalf of nearly a quarter million businesses. Since 1925, the Chamber has connected businesses of all sizes, from all sectors and from all regions of the country to advocate for public policies that will foster a strong, competitive economic environment that benefits businesses, communities and families across Canada. Most recently, the Chamber formed a National Cannabis Working Group to provide balanced policy recommendations supporting Canada's emerging cannabis sector.
"The Canadian Chamber of Commerce is very pleased to welcome Mr. Fencott to the Board of Directors. Mr. Fencott is a pioneering voice of the legal cannabis industry in Canada and Fire & Flower is regarded as a leader in this emerging market," shared Perrin Beatty, PC, OC, President and Chief Executive Officer of the Canadian Chamber of Commerce.
"It is an honour to represent the Canadian cannabis industry on the board of the Canadian Chamber of Commerce alongside some of Canada's most recognized and respected companies. The progressive outlook demonstrated by the Chamber in forming a National Cannabis Working Group is to be commended and Fire & Flower is proud to be co-chairing the initiative. Working with the Chamber creates the unique opportunity for the cannabis sector to access the nationwide Chamber network and put forward non-partisan, balanced policy recommendations that will allow the industry to move to the next level of its national and international development," shared Trevor Fencott, Chief Executive Officer of Fire & Flower.
Further details on the Canadian Chamber of Commerce policy work as it relates to the emerging cannabis industry will be published on the organization's website at www.chamber.ca.
Jushi Holdings Inc. (NEO: JUSH.B) (OTCQX: JUSHF), a globally-focused, multi-state cannabis and hemp operator, announced that the OTC Markets Group has approved the trading of the Company's subordinate voting shares on its OTCQX® Best Market under the ticker symbol 'JUSHF'. Jushi's subordinate voting shares will begin trading on the OTCQX® Market at the opening of the market today, September 23, 2019. The Company's subordinate voting shares will continue to be listed on the Neo Exchange Inc. under the ticker symbol 'JUSH.B'.
"Trading our shares on the OTCQX® Market, the premier tier of the OTC market, will raise the Company's profile by diversifying our shareholder base and enhancing share liquidity in support of our Company's long-term objectives. Qualifying to trade on the OTCQX® Market reflects our commitment to holding our Company to the highest standards of disclosure, corporate governance, and compliance," said Jim Cacioppo, CEO and Chairman of Jushi Holdings Inc.
Curaleaf New York, a subsidiary of Curaleaf Holdings Inc. (CSE: CURA) (OTC: CURLF) launched Curaleaf Ground Flower Pods - New York State's first medical cannabis flower products – at its Carle Place dispensary in Nassau County, Long Island. The product will be available at all four Curaleaf dispensaries in the coming weeks.
Now available for limited release, Curaleaf will provide New York's medical cannabis patients a new method to take their medicine by offering ground flower pods which are used in medical vaporizers. Each Curaleaf Ground Flower Pod contains 350mg of active cannabinoids – a total of 700mg per 3.5g package – in a 20:1 THC:CBD ratio in Indica and Sativa strains.
"Curaleaf is very pleased to be launching the first medical cannabis flower products to be offered in New York state, which is first and foremost a win for our patients," said Joseph Lusardi, CEO of Curaleaf. "Flower is cannabis in its raw form and therefore the most affordable form of cannabis. We can increase patient access by providing more affordable products and offering more options for patients in the medical program. We'd like to thank the Department of Health for permitting us to sell vapable flower. We believe it's an important step toward making natural products available in New York."
"As a practitioner in the Long Island area, I strive to help patients attain the most effective medicine to treat their conditions," said Dr. Grace Forde, MD, Director of Neurological Services at North American Partners in Pain Management in Long Island. "It's extremely beneficial to patients to offer more options beyond cannabis oil. In addition to being more affordable and all-natural, vaporizing cured ground flower cannabis produces effects faster than oral solutions and is therefore better suited for treating certain medical conditions."
Starting today, the Curaleaf Tabletop Vaporizer is also available for purchase. The Curaleaf Tabletop Vaporizer heats the ground cannabis to a point below combustion where the contents are released in a mild, smokeless vapor, enabling inhalation without the by-products of smoking.
Further demonstrating the company's commitment to expanding patient access, Curaleaf New York launched its delivery program earlier this year. The program, free with purchase, which runs three days a week on Thursdays, Fridays and Saturdays, is available to registered patients and their caregivers living in Nassau, Suffolk, Queens, Kings and New York Counties.
Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) announced that it has received an amended license from Health Canada and continues to make significant progress with the build out of the adjoining state of the art white label manufacturing facility scheduled for completion by H1 2020.
Under the new license, Valens is now authorized to manufacture and supply oil products directly to provincial distributors and other authorized Canadian retail supply channels. Valens will immediately start leveraging this amended license to expand services provided to its white label manufacturing partners, delivering retail ready products including tinctures and gel caps. The Company plans to further expand its retail ready product offerings to include vaporizer cartridges, beverages, topicals and other desired products as permitted by Health Canada.
"This amended license represents another significant milestone for the Company" said Tyler Robson, CEO of Valens. "We are excited to be able to utilize this license, our industry leading extraction, IP and formulation services along with our strategic partnerships with companies like Shoppers Drug Mart, to provide our white label partners access to a comprehensive service offering."
"With Valens now licensed to manufacture and supply white label products through provincial distributors we are happy to update investors on the construction of the adjoining state of the art white label facility which remains on time and on budget to be complete by H1 2020" said Tyler Robson.
Valens has already built out the capability to fulfill initial white label product demand through the Company's current extraction and product development facility. However, the new white label manufacturing facility is not only expected to increase extraction capacity to over 1,000,000kg per year through further expansion of the Company's ethanol and hydrocarbon capabilities but will substantially increase product development and manufacturing volumes of vape pens, beverages, concentrates, edibles, and topicals for its customers. The new facility will include robotics and automated machinery to enhance throughput and efficiencies of customized products for our customers.
"This is a purpose-built facility to EU GMP standards and is expected to be one of the largest and most diverse third-party cannabis product development facilities in Canada" said Tyler Robson. "We will be expanding our offerings to our customers to also include customized formulations, emulsion, terpene enhancement, and centrifugal partition chromatography that will allow our customers to target specific desired cannabinoids as the market offerings mature, such as CBG, THCV or CBN, as well as separate out unwanted contaminants in oil including pesticides and microbials."
The Company would also like to provide further insight into the strategic agreement, announced on September 16, 2019, with Shoppers Drug Mart for the supply of cannabis oil products. Under the terms of the agreement, Shoppers will purchase from the Company, retail ready products including gel caps and tinctures for sale and distribution on their medical cannabis ecommerce site, with further expansion of product offerings to include vaporizer cartridges, topicals and other desired products as permitted by Health Canada. The agreement is for an initial three-year term, with the option to renew for an additional two years with the total value of the contract being determined based on the size and frequency of purchase orders received by the Company from Shoppers. The Company already has all the infrastructure in place to execute under the agreement and continues to work closely with the team at Shoppers to finalize details for the successful launch of products.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
